Cargando…
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients
BACKGROUND: Chronic hemodialysis (HD) patients exhibit severe morpho-functional cardiac alterations, putting them at a high risk of death and adverse cardiovascular (CV) outcomes. Despite the fact that an unbalanced expression of various microRNAs (miRNAs) has been related to pathological cardiac re...
Autores principales: | Bolignano, Davide, Greco, Marta, Presta, Pierangela, Duni, Anila, Vita, Caterina, Pappas, Ethymios, Mirabelli, Maria, Lakkas, Lampros, Naka, Katerina K, Brunetti, Antonio, Foti, Daniela Patrizia, Andreucci, Michele, Coppolino, Giuseppe, Dounousi, Evangelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157794/ https://www.ncbi.nlm.nih.gov/pubmed/37151423 http://dx.doi.org/10.1093/ckj/sfad017 |
Ejemplares similares
-
Circulating miRNA 122-5p Expression Predicts Mortality and Cardiovascular Events in Chronic Hemodialysis Patients: A Multicentric, Pilot, Prospective Study
por: Duni, Anila, et al.
Publicado: (2023) -
Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients
por: Bolignano, Davide, et al.
Publicado: (2021) -
Differences in the Profile of Circulating Immune Cell Subsets in Males with Type 2 Cardiorenal Syndrome versus CKD Patients without Established Cardiovascular Disease
por: Duni, Anila, et al.
Publicado: (2023) -
Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy
por: Bolignano, Davide, et al.
Publicado: (2022) -
The Association of Circulating CD14++CD16+ Monocytes, Natural Killer Cells and Regulatory T Cells Subpopulations With Phenotypes of Cardiovascular Disease in a Cohort of Peritoneal Dialysis Patients
por: Duni, Anila, et al.
Publicado: (2021)